Cholesterol manufactured in the brain appears to play a key role in the development of Alzheimer’s disease, new research indicates. Scientists from the University of Virginia School of Medicine...

Alzheimer’s disease (AD), the most common type of dementia, causes the death of neurons and leads to shrinking of the brain. Patients with AD will eventually experience gradual deterioration in...

Poor sleep impacts the risk of long-term cognitive decline in Hispanic/Latino middle aged and older adults differently than it does in non-Hispanic adults, according to research led by University of...

Alzheimer’s disease treatments that slow progression of the disease could significantly reduce the financial burden to U.S. state budgets, according to a new USC study. The study outlines how states—which...

Diabetes type 2: Dr Zoe Williams discusses high blood sugar risks When you subscribe we will use the information you provide to send you these newsletters.Sometimes they’ll include recommendations...

(Reuters) – Eli Lilly and Co on Saturday said its experimental Alzheimer’s drug slowed the rate of decline in a measure of cognition and function by 32% compared with a placebo in a mid-stage trial...

One of the most significant genetic risk factors for developing Alzheimer’s disease is a gene called APOE4, which is carried by almost half of all Alzheimer’s patients. A new study from MIT...

The coronavirus jab’s most tantalising side effects? It may help fight cancer, chronic pain… and even Alzheimer’s Scientists have documented the unexpected benefits of vaccines for decades Some...

Researchers at University of California San Diego School of Medicine have launched a first-in-human Phase I clinical trial to assess the safety and efficacy of a gene therapy to deliver a key protein...

All Alzheimer’s disease patients and their family caregivers should be vaccinated against COVID-19, the Alzheimer’s Foundation of America says. “Getting vaccinated is one of the most...